Delivery Order SPE2DB22D2006-SPE2DB24FW3AT
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $3,293.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. It is a delivery order contract for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, including the military and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,306.93 firm fixed-price delivery order contract is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S medical products. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.96 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.12, is a delivery order from the Defense Logistics Agency (DLA), a defense agency, for the supply of a specific pharmaceutical product - BUTALB-ACETAMIN-CAFF 50-300-40 100S. The contract is for a firm fixed price and has an ultimate completion date of June 9, 2025. The award is not set aside and is open to full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,389.38, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support government healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC...
This federal contract award, valued at $1,017.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 28, 2025. The contract covers the procurement of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $1,236.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a performance period extending through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,148.28 for the supply of 4561000815 BUTALB-ACETAMIN-CAF-COD 50-325 100S pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through May 22, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,264.35 Firm Fixed Price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S medication, with a performance period through June 2025. The contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.20 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAFF 50-300-40 100S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...